Page 154 - CW E-Magazine (18-6-2024)

News from Abroad

BOOST FOR BIOPHARMA RESEARCH
Sartorius opens new bioanalytics centre

of excellence in US

German life science group Sartorius ments at this site, includ-
has opened its new Centre of Excel- ing the associated reagents,
lence for bioanalytics in Ann Arbor, consumables and software
Michigan (USA). The $100-mn facility solutions. In addition, the
consolidates the company’s existing company will provide par-
sites and functions in Ann Arbor. The ticle validation services and
number of employees at the site is produce microcarriers used
expected to double over time. in cell culture processes.

“Sartorius is a leading provider of “Ann Arbor is strategi-
highly automated bioanalytical solu- cally located at the cross-
tions that are used in the discovery and roads of talent, technology
development of innovative biopharma- said Dr. Alexandra Gatzemeyer, Head and logistics, in close proximity to cus-
ceutical drugs. We are helping scien- of the Lab Products & Services division tomers and renowned universities. The
tists to gain better, data-driven insights and member of the Executive Board opening of our new building in the Tech
and streamline their workflows, ulti- of Sartorius. Loop marks an important milestone for
mately accelerating the development Sartorius in the Americas region, offer-
of new, life-saving therapies. With our The 130,000-square-foot facility ing space for further expansion in the
new flagship site in Ann Arbor, we are houses a modern manufacturing and future,” said Mr. Maurice Phelan, Presi-
bringing together our core competen- services area, biology labs, a ware- dent of Sartorius North America. Sarto-
cies and dedicated experts under one house, office and training spaces, as rius has already been present in the city
roof, further strengthening our ability well as a Customer Interaction Centre for several years, after acquiring the
to address key customer needs in this (CIC). Sartorius will develop and manu- Ann Arbor-based businesses Essen Bio-
highly innovative and relevant field,” facture a range of bioanalytical instru- Science in 2017 and SoloHill in 2020.

EXPANDING BIOPRODUCTION FOCUS
CPhI North America concludes in Philadelphia

Pharma trade fair, CPHI North America seek increasingly secure and buying audiences and fostering new
America, concluded in Philadelphia, robust supply chain options within Bio- partnerships.
USA, in May, with participation of production.”
over 4,000 visitors and 370 exhibitors The organiser, Informa Markets, said
and strong emphasis on returning The 2024 edition of CPHI North the next year’s edition will unveil a much
growth in biologics. America featured over 80 speakers larger dedicated bioproduction area, un-
presenting on a wide array of topics derscoring the growing significance of
Ms. Sarah Griffin, Event Manager – crucial to the pharma sector’s biopharmaceutical manufacturing. This
Pharma Brand US at Informa Mar- future – from supply chain economics addition comes as a response to several
kets, commented: “This year, we have to technologies revolutionising drug key factors, including capacity con-
observed and continue to anticipate manufacturing and solutions for meet- straints at major CMOs, a notable surge
that supporting the biologics supply ing sustainability goals. A notable in FDA approvals of biologic drugs such
chain is crucial to meeting expand- highlight was the increased participa- as mAbs, advanced therapies and ADCs,
ing regional needs. This support is a tion from purchasing teams and R&D as well as a raft of strategic investments
vital aspect of the show, especially as professionals at the show, reflecting by pharmaceutical companies to enhance
pharmaceutical professionals in North the event’s focus on attracting larger their bioproduction infrastructure.

154 Chemical Weekly June 18, 2024

Contents Index to Advertisers Index to Products Advertised